01 1Concord Biotech
01 1MIDOSTAURIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-12-04
Pay. Date : 2020-07-03
DMF Number : 34976
Submission : 2020-10-27
Status : Active
Type : II
20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MIDOSTAURIN, with a corresponding US DMF Number 34976.
Remarkably, this DMF maintains an Active status since its submission on October 27, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 04, 2020, and payment made on July 03, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
